Dr. Richard Jerome Wilkerson, MD

Dr. Wilkerson practices at Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health.

Dr. Wilkerson's NPI, 1376519488, was assigned on February 28, 2006. Dr. Wilkerson graduated from University of Alabama School of Medicine in 1997. Dr. Wilkerson holds New Mexico license MD2014-0991.

Dr. Wilkerson's primary practice is Lovelace Medical Center, at 601 Dr Martin Luther King Jr Ave NE, Albuquerque, NM 87102 in Bernalillo County. The practice phone is (505) 727-8000.

Dr. Wilkerson's primary practice is Lovelace Medical Center in Albuquerque, New Mexico, part of Ardent Health. Dr. Wilkerson is also affiliated with Presbyterian Hospital. The medical group on file is Lovelace Medical Group. Dmand AI also links Dr. Wilkerson to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilkerson practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Wilkerson's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. Wilkerson's licenses on file in 3 states: New Mexico, Maryland and Texas.

CMS data shows 876 Medicare services from Dr. Wilkerson across 14 procedure codes in 2024, for 513 Medicare patients. Medicare paid $48,053 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 513 Medicare patients who saw Dr. Wilkerson in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wilkerson's median patient age at 77, with 44% women.

In 2024, Dr. Wilkerson wrote 271 Medicare Part D claims for 72 patients. 89% of them were for generic drugs. CMS names the drug for 242 of them, across 3 drugs with 11 or more claims each, at $15,357 in total drug cost. In 2023, CMS named 220 claims across 2 drugs.

Dr. Wilkerson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of leg revascularization (restoring blood flow) by Dr. Wilkerson, more than 79% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Wilkerson to 3 clinical trials. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Chronic Limb-Threatening Ischemia.

CMS Open Payments shows 687 general payments to Dr. Wilkerson from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 69% of the total. Endologix, Inc. paid the most, $12,061.

Dr. Wilkerson graduated from University of Alabama School of Medicine in 1997.